Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527
Freedman RA, Foster JC, Seisler DK, Lafky JM, Muss HB, Cohen HJ, Mandelblatt J, Winer EP, Hudis CA, Partridge AH, Carey LA, Cirrincione C, Moreno-Aspitia A, Kimmick G, Jatoi A, Hurria A. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. Journal Of Clinical Oncology 2016, 35: 421-431. PMID: 27992272, PMCID: PMC5455700, DOI: 10.1200/jco.2016.69.4182.Peer-Reviewed Original ResearchConceptsOlder patientsMetastatic trialsAdjuvant trialsBreast cancerHormone receptor-negative tumorsBreast cancer treatment trialConclusion Older patientsSystemic therapy trialsReceptor-negative tumorsBreast cancer trialsCancer treatment trialsYears of ageAccrual challengesNeoadjuvant trialsAdjuvant studiesPatient ageTherapy cessationLymph nodesTherapeutic trialsTreatment cessationTumor sizeDisease characteristicsPatient populationTreatment trialsCancer trialsAccrual of older patients (pts) with breast cancer to Alliance systemic therapy trials over time: A151527.
Freedman R, Seisler D, Foster J, Lafky J, Kimmick G, Jatoi A, Muss H, Cohen H, Mandelblatt J, Winer E, Hudis C, Cirrincione C, Moreno-Aspitia A, Hurria A. Accrual of older patients (pts) with breast cancer to Alliance systemic therapy trials over time: A151527. Journal Of Clinical Oncology 2016, 34: 1024-1024. DOI: 10.1200/jco.2016.34.15_suppl.1024.Peer-Reviewed Original Research